4.8. Total Antioxidant Capacity: ABTS and FRAP Assays

RM Renata M. Martinez
VF Victor Fattori
PS Priscila Saito
IP Ingrid C. Pinto
CR Camilla C. A. Rodrigues
CM Cristina P. B. Melo
AB Allan J. C. Bussmann
LS Larissa Staurengo-Ferrari
JB Julia Rojo Bezerra
JV Josiane A. Vignoli
MB Marcela M. Baracat
SG Sandra R. Georgetti
WJ Waldiceu A. Verri, Jr.
RC Rubia Casagrande
request Request a Protocol
ask Ask a question
Favorite

For both assays, skin samples were dissected and homogenized into ice-cold buffer containing 1.15% KCl. Homogenates were then centrifuged (1000× g in 4 °C for 10 min) [16]. A stock solution of ABTS (7mM in water) was mixed with 2.45 mM potassium persulfate (final concentration) to obtain ABTS+. Prior to the use, ABTS+ working solution was further diluted in phosphate buffer pH 7.4 to reach an absorbance of 0.8 (±0.02) at 730 nm. Briefly, the supernatant (7 μL) was added to 200 μL of the diluted ABTS+ solution; samples were vortex-mixed and allowed to stand for 6 min. Reading was performed at 730 nm. For the FRAP assay, the supernatants (30 μL) were mixed with the FRAP reagent. Prior to the use, FRAP reagent was prepared as follow: 0.3 mM acetate buffer pH 3.6, 10 mM TPTZ in 40 mM hydrochloride acid, and 20 mM ferric chloride. Reading was performed at 595 nm in a microplate reader. All results were compared to a standard curve of trolox (concentration ranging 0.01–20 nmol). Results are presented as nmol trolox equivalent per mg of skin tissue.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A